Diagnostic and treatment of fibrinothorax
https://doi.org/10.24884/0042-4625-2022-181-2-57-62
Abstract
The OBJECTIVE was to promote the official introduction into clinical practice of the term «fibrinothorax» as a separate nosological unit and a special form of exudative pleurisy. This term reflects the essence and timing of the pathological process in the pleural cavity and defines a specific set of necessary therapeutic and diagnostic measures.
METHODS AND MATHERIALS. 67 patients with fibrinothorax of different volumes were examined and treated. Two methods of pleural cavity sanitation were used: operative (thoracoscopic) and «closed» with the use of proteolytic enzymes.
RESULTS. Among 67 patients, the leading cause of fibrinothorax was nonspecific (para- and metapneumonic) pleurisy – 48 (72 %) patients. In 7 (10 %) cases, fibrinothorax was established, which complicated the course of pleurisy of tuberculous etiology. In 6 (9 %) cases, pleural effusion was a transudate, in which, against the background of repeated punctures and long periods of fluid accumulation in the pleural cavity, partial delineations in the form of fibrinothorax formed. Carcinomatous pleurisy was diagnosed in 6 (9 %) patients of the study group. Pleural cavity sanitation through the use of proteolytic enzymes was performed in 49 (73 %) of 67 patients. Thoracoscopic sanitation with biopsy for fibrinothorax was performed in 18 (27 %) patients. This material formed the basis of the concept of diagnosis of fibrinothorax and optimization of treatment.
CONCLUSION. The introduction of the term «fibrinothorax» into clinical practice, reflecting the essence of this pathological condition, contributes to the formation of a treatment and diagnostic algorithm aimed at the sanitation of the pleural cavity in optimal ways.
About the Authors
V. V. LishenkoRussian Federation
Lishenko Viktor V. - Cand. of Sci (Med.), Associate Professor, Senior Lecturer of the Department of Hospital Surgery
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
D. A. Zaytsev
Russian Federation
Zaitsev David A. - Cand. of Sci (Med.), Associate Professor, Thoracic Surgeon of the Department of Thoraco-Abdominal Surgery
4/2b, Akademika Lebedeva str., Saint-Petersburg, 194044
Competing Interests:
The authors declare no conflict of interest
A. V. Kochetkov
Russian Federation
Kochetkov Alexander V. - Dr. of Sci. (Med.), Professor, Chief Surgeon
4/2b, Akademika Lebedeva str., Saint-Petersburg, 194044
Competing Interests:
The authors declare no conflict of interest
A. A. Kurygin
Russian Federation
Kurygin Alexander A. - Dr. of Sci. (Med.), Professor, Associate Professor of the Department of Faculty Surgery named after S. P. Fedorov
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest
References
1. A large medical encyclopedia. Vol. 10 / eds by B. V. Petrovsky. Moscow, 1979:1553–1556. (In Russ.).
2. Kotiv B. N., Barinov O. V., Bashilov N. I. The role of scientists of the Military Medical Academy named after S. M. Kirov in the study of the problem of treatment of purulent-destructive diseases of the lungs and pleura // Bulletin of the Russian Military Medical Academy. 2015;1(49):189–193. (In Russ.).
3. Lishenko V. V., Zaitsev D. A. Therapeutic tactics in fibrinothorax // Pulmonology. 2010;(4):54–57. (In Russ.).
4. Zaitsev D. A., Movchan K. N., Lishenko V. V. Possibilities of modern technologies of examination and treatment of patients with fibrinothorax // International Journal of Applied and Fundamental Research. 2015;(6–3):436–439. (In Russ.)
5. Now I. V., Moskvichev B. V., Ivanova G. P. Nanobiotechnological form of therapeutic proteolytic enzyme terrilitin – terridecase // Polyclinic. 2011; (2–1):93–95. (In Russ.)
6. Yamaguchi M., Takeo S., Suemitsu R. et al Video-assisted thoracic surgery for fibropurulent thoracic empyema: a bridge to open thoracic surgery // Ann. Thorac. Cardiovasc. Surg. 2009;15(6):368–372.
7. Shneider C. R., Gauderer M. W., Blackhurst D. et al. Video-assisted thoracoscopic surgery as a primary intervention in pediatric parapneumonic effusion and empyema // Ann. Surg. 2010;76(9):957–961.
8. Allaberganov K. O. Features of the course and treatment of fibrinothorax in children // Pediatrics // The journal named after G. N. Speransky. 2006;85(1):59–61. (In Russ.).
9. Rumyantseva G. N., Yusufov A. A., Gorshkov A. Yu. Pulmonoscintigraphy in the diagnosis of fibrinothorax in children and young people // Bulletin of the Russian Scientific Center of Radiology of the Ministry of Health of Russia. 2014;(14–1):5. (In Russ.).
10. Slesarev V. V. Determination of the algorithm of local sanitation measures in children with pleural empyema // International Scientific Research Journal. 2018;9–1(75):122–124. (In Russ.).
11. Bataev S. M., Ignatiev R. O., Zurbaev N. T. Application of hydrosurgical technology in the treatment of a child with complicated pneumonia on the background of scarlet fever // Pediatrics. The journal named after G. N. Speransky. 2018;97(2):113–117. (In Russ.).
12. Kaigorodova I. N., Velik A. A., Lonshakov B. V. Videothoracoscopy in the treatment of pulmonary pleural forms of bacterial lung destruction in children // Bulletin of the Association of Surgeons of the Irkutsk region. Irkutsk, 2004:96–97. (In Russ.).
13. Sleptsov L.A., Savina V.A., Erdynev T.E. Thoracoscopic sanitation of the pleural cavity in purulent-inflammatory lung diseases in children // Russian Bulletin. 2015;5(1):74–76. (In Russ.).
Review
For citations:
Lishenko V.V., Zaytsev D.A., Kochetkov A.V., Kurygin A.A. Diagnostic and treatment of fibrinothorax. Grekov's Bulletin of Surgery. 2022;181(2):57-62. (In Russ.) https://doi.org/10.24884/0042-4625-2022-181-2-57-62